Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 26650 | 204 | 36.3 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CD69 | Author keyword | 11 | 18% | 25% | 52 |
| 2 | CD69 ANTIGEN | Author keyword | 4 | 67% | 2% | 4 |
| 3 | A20 | Address | 1 | 100% | 1% | 2 |
| 4 | BOVINE LYMPHOCYTE | Author keyword | 1 | 50% | 0% | 1 |
| 5 | CARBOXYLATED CALIXARENES | Author keyword | 1 | 50% | 0% | 1 |
| 6 | CD34 PROGENITOR CELL | Author keyword | 1 | 50% | 0% | 1 |
| 7 | CHROMOSOMAL SUBLOCALIZATION | Author keyword | 1 | 50% | 0% | 1 |
| 8 | FLUORESCENCE TRIGGERING | Author keyword | 1 | 50% | 0% | 1 |
| 9 | HOSP PRINCESS | Address | 1 | 50% | 0% | 1 |
| 10 | LYMPHOCYTE EXPANSION | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CD69 | 11 | 18% | 25% | 52 | Search CD69 | Search CD69 |
| 2 | CD69 ANTIGEN | 4 | 67% | 2% | 4 | Search CD69+ANTIGEN | Search CD69+ANTIGEN |
| 3 | BOVINE LYMPHOCYTE | 1 | 50% | 0% | 1 | Search BOVINE+LYMPHOCYTE | Search BOVINE+LYMPHOCYTE |
| 4 | CARBOXYLATED CALIXARENES | 1 | 50% | 0% | 1 | Search CARBOXYLATED+CALIXARENES | Search CARBOXYLATED+CALIXARENES |
| 5 | CD34 PROGENITOR CELL | 1 | 50% | 0% | 1 | Search CD34+PROGENITOR+CELL | Search CD34+PROGENITOR+CELL |
| 6 | CHROMOSOMAL SUBLOCALIZATION | 1 | 50% | 0% | 1 | Search CHROMOSOMAL+SUBLOCALIZATION | Search CHROMOSOMAL+SUBLOCALIZATION |
| 7 | FLUORESCENCE TRIGGERING | 1 | 50% | 0% | 1 | Search FLUORESCENCE+TRIGGERING | Search FLUORESCENCE+TRIGGERING |
| 8 | LYMPHOCYTE EXPANSION | 1 | 50% | 0% | 1 | Search LYMPHOCYTE+EXPANSION | Search LYMPHOCYTE+EXPANSION |
| 9 | IMMUNOSUPPRESSIVE CELLS | 0 | 33% | 0% | 1 | Search IMMUNOSUPPRESSIVE+CELLS | Search IMMUNOSUPPRESSIVE+CELLS |
| 10 | CD8 T CELL COUNT | 0 | 25% | 0% | 1 | Search CD8+T+CELL+COUNT | Search CD8+T+CELL+COUNT |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | AIM CD69 | 30 | 100% | 6% | 12 |
| 2 | LEU 23 | 23 | 70% | 9% | 19 |
| 3 | INDUCER MOLECULE | 19 | 70% | 8% | 16 |
| 4 | EARLY ACTIVATION ANTIGEN | 12 | 63% | 6% | 12 |
| 5 | ACTIVATION INDUCER MOLECULE | 9 | 64% | 4% | 9 |
| 6 | ACTIVATION ANTIGEN EA 1 | 8 | 100% | 2% | 5 |
| 7 | ACTIVATION ANTIGEN CD69 | 7 | 35% | 8% | 17 |
| 8 | ANTIGEN EA 1 | 6 | 50% | 4% | 9 |
| 9 | EA 1 | 6 | 100% | 2% | 4 |
| 10 | ANTIGEN CD69 | 5 | 41% | 4% | 9 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Is CD69 an effective brake to control inflammatory diseases? | 2013 | 6 | 73 | 34% |
| THE ACTIVATION ANTIGEN CD69 | 1994 | 237 | 60 | 52% |
| C-type lectin-like receptors on myeloid cells | 2006 | 25 | 100 | 22% |
| CD69 Is the Crucial Regulator of Intestinal Inflammation: A New Target Molecule for IBD Treatment? | 2015 | 0 | 127 | 29% |
| Lymphocyte activation associated antigens | 2001 | 3 | 107 | 11% |
| VERY EARLY (VEA) AND VERY LATE (VLA) ACTIVATION ANTIGENS HAVE DISTINCT FUNCTIONS IN LYMPHOCYTE-T ACTIVATION | 1989 | 39 | 34 | 9% |
| Inflammation in Circulation | 2012 | 0 | 73 | 1% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | A20 | 1 | 100% | 1.0% | 2 |
| 2 | HOSP PRINCESS | 1 | 50% | 0.5% | 1 |
| 3 | CENT NETHERLANDS RED CROSS BLOOD TRANSFUS SER | 0 | 33% | 0.5% | 1 |
| 4 | HAEMATOL MALIGNANCIES | 0 | 33% | 0.5% | 1 |
| 5 | HEMATOLSIRIRAJ HOSP | 0 | 33% | 0.5% | 1 |
| 6 | HOSP DE LA PRINCESA | 0 | 25% | 0.5% | 1 |
| 7 | UNITAT TOXICOL EXPT ECOTOXICOL | 0 | 25% | 0.5% | 1 |
| 8 | BMT PROGRAMME | 0 | 20% | 0.5% | 1 |
| 9 | TRANSPLANTAT THER Y SECT | 0 | 20% | 0.5% | 1 |
| 10 | EXPT IMMUNOL BRANCH NIH | 0 | 17% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000112199 | KIR//LY49//KILLER CELL IMMUNOGLOBULIN LIKE RECEPTORS |
| 2 | 0.0000096015 | T11TS//CD2//CD58 |
| 3 | 0.0000092682 | QUANTITAT SCI BIOMED//LABEL STRUCTURED POPULATION DYNAMICS//CFSE |
| 4 | 0.0000067644 | IMMUKNOW//IMMUNE FUNCTION ASSAY//CYLEX IMMUKNOW ASSAY |
| 5 | 0.0000064188 | XYMEDON//ANTIGEN PURIFICATION//BIOL KAZAN |
| 6 | 0.0000059296 | DOUBLE POSITIVE T CELLS//CD4CD8 T CELLS//CD8 INFECTION |
| 7 | 0.0000058043 | T CELL DEVELOPMENT//PRE T CELL RECEPTOR//THYMIC SELECTION |
| 8 | 0.0000055692 | EOSINOPHILS//EOSINOPHIL//TUMOR ASSOCIATED TISSUE EOSINOPHILIA |
| 9 | 0.0000055295 | CELLULAR CALCIUM HOMEOSTASIS//FERRIC LACTATE//PATHOL ANAT CYTOL SERV |
| 10 | 0.0000054299 | HANS WILSDORF//CLIN IMMUNOL UNITHANS WILSDORF//IMMUNOL ALLERGYCLIN IMMUNOL UNIT |